UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 346

Sortiert nach

Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer

Clinical cancer research, 2016-08, Vol.22 (15), p.3764-3773

2016

Volltextzugriff (PDF)

Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer

Journal of clinical oncology, 2010-03, Vol.28 (7), p.1145-1153

2010

Volltextzugriff (PDF)

Telomeric allelic imbalance indicates defective DNA repair and sensitivity to DNA-damaging agents

Cancer discovery, 2012-04, Vol.2 (4), p.366-375

2012

Volltextzugriff (PDF)

The Emerging Role of the Insulin‐Like Growth Factor Pathway as a Therapeutic Target in Cancer

The oncologist (Dayton, Ohio), 2008-01, Vol.13 (1), p.16-24

2008

Volltextzugriff (PDF)

Predictors of Resistance to Preoperative Trastuzumab and Vinorelbine for HER2-Positive Early Breast Cancer

Clinical cancer research, 2007-02, Vol.13 (4), p.1198-1207

2007

Volltextzugriff (PDF)

Cost‐effectiveness of alternating magnetic resonance imaging and digital mammography screening in BRCA1 and BRCA2 gene mutation carriers

Cancer, 2013-03, Vol.119 (6), p.1266-1276

2013

Volltextzugriff (PDF)

VEGF as a Marker for Outcome Among Advanced Breast Cancer Patients Receiving anti-VEGF Therapy with Bevacizumab and Vinorelbine Chemotherapy

Clinical cancer research, 2008-12, Vol.14 (23), p.7871-7877

2008

Volltextzugriff (PDF)

Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic features

Breast cancer research : BCR, 2010-01, Vol.12 (1), p.R12-R12, Article R12

2010

Volltextzugriff (PDF)

Analysis of the MammaPrint Breast Cancer Assay in a Predominantly Postmenopausal Cohort

Clinical cancer research, 2008-05, Vol.14 (10), p.2988-2993

2008

Volltextzugriff (PDF)

Trastuzumab and Vinorelbine as First-Line Therapy for HER2-Overexpressing Metastatic Breast Cancer: Multicenter Phase II Trial With Clinical Outcomes, Analysis of Serum Tumor Markers as Predictive Factors, and Cardiac Surveillance Algorithm

Journal of clinical oncology, 2003-08, Vol.21 (15), p.2889-2895

2003

Volltextzugriff (PDF)

TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer

Journal of clinical oncology, 2015-06, Vol.33 (17), p.1902-1909

2015

Volltextzugriff (PDF)

Metastatic mucinous ovarian cancer and treatment decisions based on histology and molecular markers rather than the primary location

Journal of the National Comprehensive Cancer Network, 2012-09, Vol.10 (9), p.1076

2012

Volltextzugriff (PDF)

Prevalence and predictors of loss of wild type BRCA1 in estrogen receptor positive and negative BRCA1-associated breast cancers

Breast cancer research : BCR, 2010-11, Vol.12 (6), p.R95-R95, Article R95

2010

Volltextzugriff (PDF)

A randomized phase II study of metronomic cyclophosphamide and methotrexate (CM) with or without bevacizumab in patients with advanced breast cancer

Breast cancer research and treatment, 2024-02, Vol.204 (1), p.123-132

2024

Volltextzugriff (PDF)

Annual Screening Strategies in BRCA1 and BRCA2 Gene Mutation Carriers: A Comparative Effectiveness Analysis

Cancer, 2012-04, Vol.118 (8), p.2021-2030

2012

Volltextzugriff (PDF)

Efficacy of Pegfilgrastim and Darbepoetin Alfa As Hematopoietic Support for Dose-Dense Every-2-Week Adjuvant Breast Cancer Chemotherapy

Journal of clinical oncology, 2005-11, Vol.23 (33), p.8340-8347

2005

Volltextzugriff (PDF)

A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen

Cancer cell, 2004-06, Vol.5 (6), p.607-616

2004

Volltextzugriff (PDF)

Annual screening strategies in BRCA1 and BRCA2 gene mutation carriers

Cancer, 2012-04, Vol.118 (8), p.2021-2030

2012

Volltextzugriff (PDF)

Young adult daughters of BRCA1/2 positive mothers: What do they know about hereditary cancer and how much do they worry?

Psycho-oncology (Chichester, England), 2013-09, Vol.22 (9), p.2024-2031

2013

Volltextzugriff (PDF)

Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers

Radiology, 2010-03, Vol.254 (3), p.793

2010

Volltextzugriff (PDF)

Multifocal and Multicentric Breast Cancer is Associated with Increased Local Recurrence Regardless of Surgery Type

The breast journal, 2015-03, Vol.21 (2), p.121-126

2015

Volltextzugriff (PDF)

Faciocutaneous Cancer Syndromes: Spot the Diagnosis

The oncologist (Dayton, Ohio), 2012-07, Vol.17 (7), p.886-887

2012

Volltextzugriff (PDF)

Breast cancer screening in BRCA1 mutation carriers: effectiveness of MR imaging--Markov Monte Carlo decision analysis

Radiology, 2008-03, Vol.246 (3), p.763

2008

Volltextzugriff (PDF)

Adjuvant Hormonal Therapy in Peri‐ and Postmenopausal Breast Cancer

The oncologist (Dayton, Ohio), 2006-07, Vol.11 (7), p.718-731

2006

Volltextzugriff (PDF)

Intermittent Letrozole Therapy for Metastatic Breast Cancer: Case Reports and Literature Review

Clinical breast cancer, 2014-04, Vol.14 (2), p.e41-e45

2014

Volltextzugriff (PDF)

1 – 25 von 346

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(322)
Mit Volltextzugriff
(301)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer

Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer

Telomeric allelic imbalance indicates defective DNA repair and sensitivity to DNA-damaging agents

The Emerging Role of the Insulin‐Like Growth Factor Pathway as a Therapeutic Target in Cancer

Predictors of Resistance to Preoperative Trastuzumab and Vinorelbine for HER2-Positive Early Breast Cancer

Cost‐effectiveness of alternating magnetic resonance imaging and digital mammography screening in BRCA1 and BRCA2 gene mutation carriers

VEGF as a Marker for Outcome Among Advanced Breast Cancer Patients Receiving anti-VEGF Therapy with Bevacizumab and Vinorelbine Chemotherapy

Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic features

Analysis of the MammaPrint Breast Cancer Assay in a Predominantly Postmenopausal Cohort

Trastuzumab and Vinorelbine as First-Line Therapy for HER2-Overexpressing Metastatic Breast Cancer: Multicenter Phase II Trial With Clinical Outcomes, Analysis of Serum Tumor Markers as Predictive Factors, and Cardiac Surveillance Algorithm

TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer

Metastatic mucinous ovarian cancer and treatment decisions based on histology and molecular markers rather than the primary location

Prevalence and predictors of loss of wild type BRCA1 in estrogen receptor positive and negative BRCA1-associated breast cancers

A randomized phase II study of metronomic cyclophosphamide and methotrexate (CM) with or without bevacizumab in patients with advanced breast cancer

Annual Screening Strategies in BRCA1 and BRCA2 Gene Mutation Carriers: A Comparative Effectiveness Analysis

Efficacy of Pegfilgrastim and Darbepoetin Alfa As Hematopoietic Support for Dose-Dense Every-2-Week Adjuvant Breast Cancer Chemotherapy

A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen

Annual screening strategies in BRCA1 and BRCA2 gene mutation carriers

Young adult daughters of BRCA1/2 positive mothers: What do they know about hereditary cancer and how much do they worry?

Cost-effectiveness of breast MR imaging and screen-film mammography for screening BRCA1 gene mutation carriers

Multifocal and Multicentric Breast Cancer is Associated with Increased Local Recurrence Regardless of Surgery Type

Faciocutaneous Cancer Syndromes: Spot the Diagnosis

Breast cancer screening in BRCA1 mutation carriers: effectiveness of MR imaging--Markov Monte Carlo decision analysis

Adjuvant Hormonal Therapy in Peri‐ and Postmenopausal Breast Cancer

Intermittent Letrozole Therapy for Metastatic Breast Cancer: Case Reports and Literature Review

Suchergebnisse filtern